Lifastuzumab vedotin Antibody

SKU: orb2302560

Description

Lifastuzumab vedotin is an antibody-drug conjugate (ADC) targeting NaPi2b and delivering the cytotoxic payload MMAE to inhibit tubulin polymerization. It is a research tool for studying non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC) in both in vitro and in vivo experimental models.

Research Area

Pharmacology & Drug Discovery

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Target	Sodium-dependent phosphate transporter,Antibody-Drug Conjugates (ADCs)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Sodium-dependent phosphate transporter,Antibody-Drug Conjugates (ADCs)

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols